Upload

Loading...

Prostate Cancer - European Multidisciplinary Cancer Congress 2011

1,601

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Sep 25, 2011

ESMO interviews Karim Fizazi, MD, PhD about the overall survival benefit of Radium-223 Chloride in the treatment of patients with symptomatic bone metastases in castration-resistant prostrate cancer - a Phase III randomized trial (ALSYMPCA). http://www.esmo.org

Video produced by the European Society for Medical Oncology (ESMO)

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up Next


Sign in to add this to Watch Later

Add to